Metabolic Syndrome and Gen-polymorphs Influence on Weightloss Among Children in Treatment for Overweight

Sponsor
Zealand University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00823277
Collaborator
Holbaek Sygehus (Other), University of Copenhagen (Other), Hagedorn Research Institute (Other), The Novo Nordisk Foundation Center for Basic Metabolic Research (Other), Herlev Hospital (Other)
517
1
43
12

Study Details

Study Description

Brief Summary

Definition:

the overall objective is to examine childhood obesity with focus on NAFLD and its treatment. Further, we aimed to investigate the impact of genetic variation on obesity.

The specific aims are to;

  • describe the degree of NAFLD among overweight and obese, Danish children. (hypothesis; the degree for pediatric NAFLD among Danish Children was equal that found in other Caucasian paediatric study populations).

  • investigate the effect of a multidisciplinary intervention treatment of 1 year on liver fat content.

(hypothesis; the intervention could reduce the liver fat percentage and a reduction in BMI SDS would associate with a reduction in liver fat content) - Analyze changes in liver fat content in relation to changes in levels of fasting blood variables to see if any of them could be used as a clinical tool for monitoring hepatic steatosis in the clinic.

(hypothesis; serum aminotransferases (separately and their ratio, respectively), serum insulin, and HOMA-IR could predict improvement in liver fat content

  • Investigate the association between genetic variants and obesity.
Condition or Disease Intervention/Treatment Phase
  • Other: Chronic care multidisciplinary intervention of childhood obesity

Study Design

Study Type:
Observational
Actual Enrollment :
517 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Indicators for the Metabolic Syndrome as Well as the Influence of Different Gen-polymorphs on Weightloss and the Maintenance of Lower Weight Among Children in Treatment for Overweight
Study Start Date :
Jan 1, 2009
Actual Primary Completion Date :
Aug 1, 2012
Actual Study Completion Date :
Aug 1, 2012

Arms and Interventions

Arm Intervention/Treatment
1

Overweight and obese Children (BMI SDS > 90th percentile according to Danish BMI sheets) 5-20 Years of age. Recruited from the Paediatric department, University Hospital Holbaek, Region Zealand, Denmark, University of Copenhagen

Other: Chronic care multidisciplinary intervention of childhood obesity
Overweight and obese Children, 5-20 Years old, followed by Paediatricians and other Health Personals (multidisciplinary team). Included at their first visit in the clinic (baseline)and follow-up after ~ 1 Year.

Outcome Measures

Primary Outcome Measures

  1. weightloss [1 Year]

Secondary Outcome Measures

  1. NAFLD (non-alcoholic Fatty Liver Disease).Gene-polymorphs [1 Year]

    Nafld measured by Magnet resonance spectroscopy. Sequencing of MC4R

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Years to 20 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 5- 20 Years old.

  • Adipose. BMI > 90 % percentile

  • New patient in the Children's Obesity Clinic, Paediatric Department, University Hospital Holbaek,Region Zealand, Denmark

  • Informed Consent

Exclusion Criteria:
  • Drop-outs

Contacts and Locations

Locations

Site City State Country Postal Code
1 The Children's Obesity Clinic, Paediatric Department, University Hospital Holbaek, Region Zealand, University of Copenhagen Holbaek Denmark 4300

Sponsors and Collaborators

  • Zealand University Hospital
  • Holbaek Sygehus
  • University of Copenhagen
  • Hagedorn Research Institute
  • The Novo Nordisk Foundation Center for Basic Metabolic Research
  • Herlev Hospital

Investigators

  • Principal Investigator: Dorthe S. Bille, MD, Paediatric department, University Hospital Holbaek, Region Zealand, University of Copenhagen, Denmark

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jens Christian Holm, MD, Ph.D., Zealand University Hospital
ClinicalTrials.gov Identifier:
NCT00823277
Other Study ID Numbers:
  • 130109
  • SJ-98
First Posted:
Jan 15, 2009
Last Update Posted:
Jul 20, 2022
Last Verified:
Jul 1, 2022

Study Results

No Results Posted as of Jul 20, 2022